✦ LIBER ✦

CA 19-9 as a biomarker in advanced pancreatic cancer patients randomised to gemcitabine plus axitinib or gemcitabine alone

✍ Scribed by Wasan, H S; Springett, G M; Chodkiewicz, C; Wong, R; Maurel, J; Barone, C; Rosbrook, B; Ricart, A D; Kim, S; Spano, J-P

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of gemcitabine plus axitinib co

✍ Jean-Philippe Spano; Catherine Chodkiewicz; Joan Maurel; Ralph Wong; Harpreet Wa 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 191 KB

Cetuximab plus gemcitabine and cisplatin

✍ Stefano Cascinu; Rossana Berardi; Roberto Labianca; Salvatore Siena; Alfredo Fal 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 116 KB

Pretreatment CA 19-9 Level as a Prognost

✍ Saad, Everardo D. ;Machado, Marcel C. ;Wajsbrot, Dalia ;Abramoff, Roberto ;Hoff, 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 88 KB

CA19-9 as a predictor of tumor response

✍ Nazik HAMMAD; Lance K HEILBRUN; Philip A PHILIP; Anthony F SHIELDS; Mark M ZALUP 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB

Serum CA19-9 response as a surrogate for

✍ Ko, A H; Hwang, J; Venook, A P; Abbruzzese, J L; Bergsland, E K; Tempero, M A 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 90 KB

CA 19-9 tumour-marker response to chemot

✍ Viviane Hess; Bengt Glimelius; Philipp Grawe; Daniel Dietrich; György Bodoky; Th 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 186 KB